Key Insights

Highlights

Success Rate

84% trial completion

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 52/100

Termination Rate

8.9%

7 terminated out of 79 trials

Success Rate

84.4%

-2.1% vs benchmark

Late-Stage Pipeline

19%

15 trials in Phase 3/4

Results Transparency

21%

8 of 38 completed with results

Key Signals

8 with results84% success

Data Visualizations

Phase Distribution

47Total
Not Applicable (21)
Early P 1 (1)
P 1 (2)
P 2 (8)
P 3 (13)
P 4 (2)

Trial Status

Completed38
Recruiting18
Unknown9
Terminated7
Withdrawn4
Not Yet Recruiting2

Trial Success Rate

84.4%

Benchmark: 86.5%

Based on 38 completed trials

Clinical Trials (79)

Showing 20 of 20 trials
NCT05851391Phase 2Recruiting

buRst-supprESsion TO Stop Refractory Status Epilepticus Post-cardiac Arrest

NCT06401707Phase 2Recruiting

PeRampanel fOr Status ePilEpticus pRophylaxis Post-cardiac Arrest

NCT05756621CompletedPrimary

Dual Anti-glutamate Therapy in Super-refractory Status Epilepticus After Cardiac Arrest

NCT07689084Not ApplicableCompleted

Training Program to Improve EEG Competence

NCT06100978Recruiting

Patient-reported Outcome and Patient-reported Experience After Status Epilepticus

NCT04189471Recruiting

Improving Outcomes for Patients With Life-Threatening Neurologic Illness

NCT06441760Not ApplicableRecruiting

Simulation Trial of Telemedical Support for Paramedics

NCT05140265Recruiting

De-identified UNMH EEG Corpus Database Creation With Fully De-identified Clinical Information

NCT07614074Recruiting

Recovery Trajectory for Coma and Disorders of Consciousness

NCT04421846Not ApplicableRecruitingPrimary

Study of Pathophysiology of Status Epilepticus and Dysimmune Encephalitis

NCT06907173Phase 3RecruitingPrimary

Ketamine add-on Therapy for Established Status Epilepticus Treatment Trial (KESETT)

NCT04170491Not ApplicableRecruitingPrimary

EEG Monitoring for Refractory Status Epilepticus

NCT06194747Not ApplicableRecruitingPrimary

Improving Status Epilepticus Treatment Times

NCT07443241CompletedPrimary

Status Epilepticus in Men and Women: Clinical Presentation, Management, and Outcomes

NCT07410624Recruiting

Augmented Renal Clearance in Neurocritical Care

NCT07383779Phase 3Not Yet Recruiting

Targeted Hypothermia Versus Targeted Normothermia After Convulsive Refractory Status Epilepticus

NCT07163572Not ApplicableCompletedPrimary

Comparison of Intravenous Brivaracetam Versus Levetiracetam in the Management of Status Epilepticus

NCT05418634CompletedPrimary

Point-of-care EEG in the Pediatric Emergency Department

NCT06067750Completed

Comparison of Narcotrend and Cerebral Function Analysing Monitor in Intensive Care to Monitor Seizures and Deep Sedation

NCT07052136Not ApplicableCompletedPrimary

Efficacy Comparison Between Levetiracetam and Valproic Acid in Pediatric Patients With Status Epilepticus

Scroll to load more

Research Network

Activity Timeline